CorMedix (CRMD) Tax Provisions (2011 - 2025)
CorMedix's (CRMD) quarterly Tax Provisions came in at $42.4 million in Q4 2025, up 18446315.22% year-on-year from N/an in Q4 2024, and up 175.78% quarter-over-quarter from -$56.0 million in Q3 2025.
CorMedix (CRMD) Tax Provisions (2011 - 2025) Analysis & Trends
CorMedix has disclosed Tax Provisions across 7 years of filings, most recently posting $42.4 million for Q4 2025.
- Tax Provisions for Q4 2025 came in at $42.4 million, up 18446315.22% year-over-year; the trailing twelve-month figure through Dec 2025 was -$13.0 million (down 834.71% YoY), and the FY2025 annual result was -$13.0 million, down 834.7% from the prior year.
- Tax Provisions came in at $42.4 million for Q4 2025 at CorMedix, up from -$56.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $42.4 million in Q4 2025 to a low of -$56.0 million in Q3 2025.
- The 4-year median for Tax Provisions is -$292923.5 (2022), against an average of -$1.8 million.
- Across the five-year window, Tax Provisions plunged 71.16% in 2021 and soared 18446315.22% in 2025, its largest moves.
- CorMedix's Tax Provisions stood at $1.9 million in 2021, then sank by 131.21% to -$585617.0 in 2022, then surged by 99.96% to -$230.0 in 2024, then jumped by 18446315.22% to $42.4 million in 2025.
- The last three Tax Provisions figures came in at $42.4 million (Q4 2025), -$56.0 million (Q3 2025), and $521507.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | 42.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42.43 Mn |
| Sep 30, 2025 | -55.99 Mn |
| Jun 30, 2025 | 521,507.00 |
| Dec 31, 2024 | -230.00 |
| Mar 31, 2024 | -1.39 Mn |
| Jun 30, 2022 | -585,617.00 |
| Dec 31, 2021 | 1.88 Mn |
| Jun 30, 2021 | -1.25 Mn |
| Dec 31, 2020 | 6.51 Mn |
| Jun 30, 2020 | -5.17 Mn |
| Dec 31, 2019 | 11.08 Mn |
| Jun 30, 2019 | -5.06 Mn |
| Dec 31, 2011 | -493,855.00 |